Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.
AMCo is the result of the merger of Amdipharm and the Mercury Pharma Group to create a single, consolidated, international specialty pharmaceuticals company by the company's private equity owners, Cinven.
Amdipharm Mercury (AMCo) has a broad product portfolio spanning across various territories. For more information please visit our Products page.
Consultant anaesthetists share their knowledge and experience of Prilotekal. To find out more click here